Andlauer Healthcare Group Inc.
AND.TO · TSX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CA$1,700 | CA$1,714 | CA$1,980 | CA$2,109 |
| - Cash | CA$40 | CA$60 | CA$66 | CA$25 |
| + Debt | CA$181 | CA$128 | CA$163 | CA$187 |
| Enterprise Value | CA$1,840 | CA$1,782 | CA$2,077 | CA$2,271 |
| Revenue | CA$650 | CA$648 | CA$648 | CA$440 |
| % Growth | 0.4% | -0.1% | 47.3% | – |
| Gross Profit | CA$147 | CA$147 | CA$159 | CA$111 |
| % Margin | 22.6% | 22.8% | 24.5% | 25.2% |
| EBITDA | CA$167 | CA$167 | CA$175 | CA$157 |
| % Margin | 25.6% | 25.8% | 27% | 35.8% |
| Net Income | CA$64 | CA$66 | CA$76 | CA$90 |
| % Margin | 9.9% | 10.2% | 11.8% | 20.4% |
| EPS Diluted | 1.58 | 1.55 | 1.79 | 2.25 |
| % Growth | 1.9% | -13.4% | -20.4% | – |
| Operating Cash Flow | CA$124 | CA$104 | CA$137 | CA$84 |
| Capital Expenditures | -CA$20 | -CA$26 | -CA$28 | -CA$10 |
| Free Cash Flow | CA$104 | CA$79 | CA$109 | CA$74 |